Cargando…
Semaphorin-3A protects against neointimal hyperplasia after vascular injury
BACKGROUND: Neointimal hyperplasia is a prominent pathological event during in-stent restenosis. Phenotype switching of vascular smooth muscle cells (VSMCs) from a differentiated/contractile to a dedifferentiated/synthetic phenotype, accompanied by migration and proliferation of VSMCs play an import...
Autores principales: | Wu, Jie-hong, Zhou, Yi-fan, Hong, Can-dong, Chen, An-qi, Luo, Yan, Mao, Ling, Xia, Yuan-peng, He, Quan-wei, Jin, Hui-juan, Huang, Ming, Li, Ya-nan, Hu, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355729/ https://www.ncbi.nlm.nih.gov/pubmed/30579864 http://dx.doi.org/10.1016/j.ebiom.2018.12.023 |
Ejemplares similares
-
Age-related changes in monocytes exacerbate neointimal hyperplasia after vascular injury
por: Martinez, Laisel, et al.
Publicado: (2015) -
Sodium Ferulate Inhibits Neointimal Hyperplasia in Rat Balloon Injury Model
por: Zhang, Jing, et al.
Publicado: (2014) -
Notch Signaling in Endothelial Cells: Is It the Therapeutic Target for Vascular Neointimal Hyperplasia?
por: Tian, Ding-Yuan, et al.
Publicado: (2017) -
Wood-Derived Vascular Patches Loaded With Rapamycin Inhibit Neointimal Hyperplasia
por: Xie, Boao, et al.
Publicado: (2022) -
Celastrol ameliorates vascular neointimal hyperplasia through Wnt5a-involved autophagy
por: Shi, Ya-Ning, et al.
Publicado: (2021)